CymitQuimica logo

CAS 1025821-33-3

:

Trier par

Degré de pureté (%)
0
100
|
0
|
50
|
90
|
95
|
100
6 produits concernés.
  • GSK-626616

    CAS :
    GSK-626616: strong, oral DYRK3 inhibitor (IC50: 0.7 nM), affects DYRK family, may treat anemia.
    Formule :C18H10Cl2N4OS
    Degré de pureté :98.27%
    Couleur et forme :Solid
    Masse moléculaire :401.27
  • (5Z)-2-[(2,6-Dichlorophenyl)amino]-5-(6-quinoxalinylmethylene)-4(5H)-thiazolone

    CAS :
    Formule :C18H10Cl2N4OS
    Degré de pureté :98%
    Couleur et forme :Solid
    Masse moléculaire :401.2692

    Ref: IN-DA01ENHC

    5mg
    213,00€
    10mg
    269,00€
    25mg
    532,00€
    50mg
    À demander
    100mg
    À demander
  • GSK-626616

    CAS :
    <p>GSK-626616</p>
    Degré de pureté :≥98%
    Masse moléculaire :401.27g/mol

    Ref: 54-BUP04439

    1mg
    70,00€
    5mg
    147,00€
    10mg
    221,00€
    25mg
    400,00€
    50mg
    727,00€
    100mg
    1.031,00€
  • GSK 626616

    CAS :
    <p>Potent inhibitor of dual specificity tyrosine-phosphorylation-regulated kinase 3 (DYRK3) with IC50 value of 0.7 nM. Elevates hemoglobin and platelet levels in anemic mice.</p>
    Formule :C18H10Cl2N4OS
    Degré de pureté :Min. 98 Area-%
    Couleur et forme :Powder
    Masse moléculaire :401.27 g/mol

    Ref: 3D-BG166664

    25mg
    350,00€
    50mg
    522,00€
    100mg
    829,00€
    250mg
    1.627,00€
  • GSK 626616 - Bio-X ™

    CAS :
    This product is part of our Bio-X ™ Range. These products are aimed at life science researchers who need high quality ready-to-use products for assay development, screening or other R&D work. With a solubility datasheet and convenient vials, all of our Bio-X ™ products are in stock across our global warehouses for rapid delivery and ease of use.
    Formule :C18H10Cl2N4OS
    Degré de pureté :Min. 95%
    Couleur et forme :Powder
    Masse moléculaire :401.27 g/mol

    Ref: 3D-BG300011

    10mg
    218,00€
  • GSK-626616

    Produit contrôlé
    CAS :
    <p>Applications GSK-626616 is a potent and selective DYRK inhibitor (IC50 = 0.7 nM for DYRK3, similar potency for DYRK1 and 2). Exhibits ~20-fold selectivity over casein kinase 2 and negligible activity against a panel of 451 kinases screened. Enhances number of CFU-E stimulated by Epo from human marrow. Increases hemoglobin levels in anemic mice. Orally bioavailable.<br>References Wippich, Frank., et al.: Cell., 152, 791(2013); Corona, John A., et al.: Org. Process Res. Dev., 14, 712 (2010)<br></p>
    Formule :C18H10Cl2N4OS
    Couleur et forme :Yellow
    Masse moléculaire :401.27

    Ref: TR-G797853

    5mg
    145,00€